Recent Additions

Spear-T Liquid Concentrate by Venter Institute + Vestaron
Biotech components: Gene Editing + Molecule + Yeast
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/17 11:00 (2 months ago)
Date last modified: 2019/09/17 11:00 (2 months ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical + Plant
Production process: N/A
Source: N/A
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Bacteria + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 months ago)
Date last modified: 2019/09/16 16:29 (2 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 months ago)
Date last modified: 2019/09/13 11:47 (2 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical + Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 months ago)
Date last modified: 2019/09/13 11:47 (2 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 months ago)
Date last modified: 2019/09/13 11:47 (2 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 months ago)
Date last modified: 2019/09/13 11:47 (2 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (2 months ago)
Date last modified: 2019/09/13 11:47 (2 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Chemical + Other (Industrial)
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
GM Yeast to make Cannabis by University of California, Berkeley + Demetrix Inc.
Biotech components: Yeast
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:18 (2 months ago)
Date last modified: 2019/09/12 15:18 (2 months ago)
Known funding amount: 11,000,000 USD
Funding types: Venture Capital
Industry: Medical
Market status: Early Stage Concept
Organization type(s): Private Company + University
Product categories: Medicine
Production process: N/A
Source: Scientist Magazine
Trading symbol: N/A
Value chain stage: Input
Biotech components: Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:18 (2 months ago)
Date last modified: 2019/09/12 15:18 (2 months ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medical Treatment + Medicine
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
AZT-04 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:15 (2 months ago)
Date last modified: 2019/09/12 15:15 (2 months ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product